
WB DW-MRI and 18 F-FDG PET/TC are valuable tools for the diagnosis and follow-up of MM. 18 F-FDG PET/CT is considered the gold standard for assessing extramedullary disease, while WB-DWI offers greater sensitivity in detecting diffuse disease, especially in cases of non-nonsecretory myeloma (figure 1).
A standardized protocol has been proposed for WB DW-MRI (figure 2).
On MRI, signs of the disease include (figures 3 y 4 ):
- Focal or diffuse signal intensity (SI) abnormalities with a diameter > 5 mm.
- Paramedullary or extramedullary soft-tissue lesions.
- Pathological vertebral fractures.
- Restricted Diffusion with Apparent Diffusion Coefficient (ADC) values between 600–1000 µm2 /sec.
On PET/TC with18 F-FDG, signs of the disease include (figure 5 ):
- Hypodense, lytic, or punch-out osseous lesions with a diameter > 5 mm.
- Diffuse disease: homogeneous standardized uptake values (SUVmax) of the bone marrow greater than liver, or heterogeneous bone marrow uptake.
- Focal lesions: osseous hyperactive metabolic foci greater than physiological bone marrow uptake.
- Paramedullary or Extramedullary soft-tissue lesions.
Multiple myeloma (MM) disease patterns include (figures 6, 7, 8 y 9 ):
- Diffuse pattern: generalized involvement of the bone marrow, which can be homogeneous or heterogeneous.
- Focal on diffuse / combined: independent, well-defined lesions or generalized involvement with some well-defined lesions.
- Micronodular / Variegated / Salt and Pepper" pattern: extensive involvement with nodular lesions <5 mm.
- Paramedullary pattern: bone marrow lesion.
- Extramedullary pattern: soft tissue injury that is not in continuity with spinal disease. Bone lesion.